The aim of this study was to investigate the underlying mechanisms of Tangshen formula (TSF) for treatment of diabetic kidney disease (DKD).
Background
Diabetes is the third most common chronic disease worldwide (after cancer and cardiovascular diseases) and is associated with economic development. According to the International Diabetes Federation, 366 million people had diabetes in 2011 and this will reach 552 million by year 2030 [1] . China is one of the countries with the largest numbers of people with diabetes (90.0 million in 2011 and 129.7 million by 2030) [1] . Diabetic kidney disease (DKD) is the most prevalent and serious microvascular complication following diabetes. It is estimated that DKD is developed concomitantly in more than 60% of persons with diabetes [2] . Persistent albuminuria/proteinuria excretion indicates kidney function is damaged. DKD is difficult to reverse and easily progresses to chronic renal failure and end-stage renal disease, ultimately resulting in disability or death [3] . Thus, diabetes-associated DKD has become a significant public health problem that needs to be addressed.
Currently, DKD can be managed by glycemic control, antihypertensive drugs (angiotensin-converting enzyme, angiotensin receptor blocker, and calcium channel blocker) and antilipemic agents [4] [5] [6] . Although all these treatments seem to be effective, adverse reactions (e.g., hypotension, hyperkalemia, renal, urinary and respiratory disorders) after long-term use have been well documented [7, 8] . Thus, investigation of more effective and safe treatment strategies is a clinically important issue.
Compared with target-oriented Western medicine, Traditional Chinese Medicine (TCM) maintains the body's normal function or homeostasis based on a holistic and synergistic theory to restore the balance of Yin-Yang of body energy [9] . In addition, TCM uses a combination of plants, minerals, and animal parts for treatment of diseases, several of which are medicinal and edible, inducing few adverse effects [10] . Therefore, TCM treatment is suggested as an effective and safe alternative for treatment of DKD [10, 11] . Tangshen formula (TSF) is a commonly prescribed Chinese herbal medicine for diabetic renal injuries. A recent prospective, multicenter, double-blind, randomized, controlled study has demonstrated the significant benefit of TSF in decreasing proteinuria and improving estimated glomerular filtration rate in DKD patients compared with placebo [12] . Further studies indicate TSF may attenuate DKD by inhibiting zinc finger and BTB domain containing 16 (ZBTB16/PLZF) expression [13] , transforming growth factor beta (TGF-b)/SMAD family member 3 (Smad3)/nuclear factor kappa B subunit (NF-kB) signaling pathways [14] , and activating Janus kinase (JAK)/signal transducer and activator of transcription (STAT)/suppressor of cytokine signaling (SOCS) signaling pathway [15] . However, the mechanism of TSF in DKD treatment remains unclear.
The goal of this study was to further explore the molecular mechanisms of TSF treatment for DKD by collecting microarray dataset GSE90842 from the National Center of Biotechnology Information Gene Expression Omnibus (NCBI GEO) public database [13] and analyzing it by a series of bioinformatics software. Compared with the study of Zhao et al. [13] , a non-strict threshold (P<0.05 and |logFC (fold change) | >0.1 vs. |logFC| >0.5) was selected to obtain more differentially-expressed genes (DEGs), and DEGs were run between the 2 groups by t test but not among the 3 groups by one-way ANOVA. The crucial DEGs were subsequently identified by construction of a protein and protein interaction (PPI) network and module analysis. The underlying microRNAs (miRNAs) regulating DEGs and the small molecular drugs having similar functions to TSF were also predicted. These studies were not performed by Zhao et al. [13] . Our findings may provide new insights into the mechanisms of TSF treatment for DKD.
Material and Methods

Microarray data
Microarray dataset GSE90842 was downloaded from NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/), which included renal cortical tissue samples from 20-week-old male C57BLKS/J db/m mice (normal control group, NC, n=3), 20-week-old male C57BLKS/J db/db mice (DKD group, n=3), and db/db mice given TSF by intra-gastric gavage (2.4 g/kg/day) for 12 weeks (TSF group, n=3). The non-treatment mice were administered saline. Experiments were approved by the Ethics Committee of the China-Japan Friendship Institute of Clinical Medical Sciences and performed in accordance with the NIH Guiding Principles for the Care and Use of Laboratory Animals [13] .
Data normalization and DEGs identification
The raw CEL files were preprocessed and normalized using the Robust Multichip Average (RMA) algorithm [16] in the R Bioconductor affy package (http://www.bioconductor.org/packages/release/bioc/html/affy.html). The DEGs between DKD and NC/TSF group were screened using the Linear Models for Microarray data (LIMMA) method [17] in the Bioconductor R package (http://www.bioconductor.org/packages/release/bioc/ html/limma.html). The cutoff point of P<0.05 and |logFC| >0.1 were set to obtain more DEGs. A heatmap of DEGs was constructed using R package pheatmap (http://cran.r-project.org/ web/packages/pheatmap/index.html). A Venn diagram was constructed to screen the DEGs between DKD and NC groups that were reversed by TSF treatment using an online tool (http:// bioinformatics.psb.ugent.be/webtools/Venn/).
PPI network construction
The DEGs were mapped into the PPI data retrieved from the STRING 10.0 (Search Tool for the Retrieval of Interacting Genes; http://string db.org/) database [18] to construct the PPI network, with the threshold value set as the combined scores >0.9. The PPI network was visualized using Cytoscape software 2.8 (www.cytoscape.org/) [19] . The hub genes with more interactions with other genes (degree) were selected and plotted with ggplot2 in R package (http://www.R-project.org/). To identify functionally related and highly interconnected clusters from the PPI network, module analysis was then conducted using the Molecular Complex Detection (MCODE) plugin of Cytoscape software. The parameters were set as: degree cutoff=6, node score cutoff=0.2, k-core=5, and maximum depth=100 (ftp:// ftp.mshri.on.ca/pub/BIND/Tools/MCODE) [20] . Modules with MCODE score ³4 and nodes ³6 were considered significant.
miRNA prediction
The DEGs-related miRNAs were predicted using the Mirwalk2 database (http://www.zmf.umm.uni-heidelberg.de/apps/zmf/ mirwalk2) [21] , which provides the largest collection of predicted and experimentally verified miR-target interactions with various miRNA databases. Then, the miRNA-target gene interaction network was constructed and visualized using Cytoscape software 2.8 (www.cytoscape.org/) [19] .
Function enrichment analysis
Kyoto encyclopedia of genes and genomes (KEGG) pathway and Gene ontology (GO) enrichment analyses were carried out to explore the underlying functions of all DEGs and genes in PPI network and modules using the Database for Annotation, Visualization and Integrated Discovery (DAVID) 6.8 online tool (http://david.abcc.ncifcrf.gov). P<0.05 was set as the threshold to screen the significant GO biological process (BP) terms and KEGG.
Screening of small-molecule drugs similar to TSF treatment
The Connectivity Map (CMAP, http://www.broadinstitute.org/ cmap/), which contains more than 7000 expression signatures involving 6100 small molecules as treatment-control pairs, was used to compare the DEGs with genes perturbed by small molecules in the CMAP database, to identify underlying drugs associated with these DEGs. A correlation score for each corresponding small molecule was calculated, ranging from -1 to 1. A high positive connectivity score (close to +1) indicates that the corresponding small molecule induced the expression of the query signature, while a high negative connectivity score (close to -1) indicates that the corresponding small molecule reversed the expression of the query signature. Significant small-molecule drugs were selected according to the threshold value of p<0.05 and |mean| >0.4.
Results
Identification of DEGs
According to the threshold of p<0.05 and |logFC| >0.1, there were 2277 genes identified as DEGs between NC and DKD groups, including 1138 upregulated and 1139 downregulated genes, while 2182 genes were identified as DEGs between TSF and DKD groups, including 1152 upregulated and 1130 downregulated genes. The clustering analysis in heatmap indicated that the identified DEGs perform well in distinguishing between the 2 groups (Figure 1 ).
Further, a Venn diagram was used to obtain the overlap of the upregulated (downregulated) DEGs between NC and DKD with the downregulated (upregulated) DEGs between TSF and DKD (i.e., the DEGs changed in DKD can be reversed by TSF). As a result, 193 common DEGs (including 4 miRNAs) were identified between the upregulated DEGs of NC and DKD comparison and the downregulated DEGs of TSF and DKD comparison (defined as downregulated), while 180 common DEGs (including 14 miRNAs) were identified between downregulated DEGs of NC and DKD comparison and the upregulated DEGs of TSF and DKD comparison (defined as upregulated) ( Figure 2 , Table 1 ).
Function enrichment analysis for common DEGs
The potential functions of all common DEGs were predicted by the online tool DAVID. As a result, 12 GO 
PPI network construction and modules analysis for DEGs
A PPI network was constructed to screen crucial genes associated with TSF treatment, including 106 nodes (59 upregulated and 47 downregulated) and 143 edges (interaction relationships) ( Figure 3 ). After calculating the degree, Racgap1 (degree=12), Asf1b (degree=9) and Anln (degree=6) were found to be hub genes ( Figure 3 ). In addition to regulation of cell proliferation, cell cycle, and nerve conduction, the DEGs in PPI were also involved in circadian rhythm (aryl hydrocarbon receptor nuclear translocator-like, Arntl: logFC=-1.01, p-value=3.81E-02, NC vs. DKD; logFC=0.62, p-value=3.96E-02, TSF vs. DKD) (Table 3) . Further, 1 significant module was screened from the PPI network (Figure 4 ), which was also enriched into cell division-and cell cycle-related GO terms (without no pathways enriched), demonstrating these processes may be especially important mechanisms for TSF treatment (Table 4) .
DEGs-related miRNAs
After searching the Mirwalk2 database, 145 miRNAs were found to regulate the above common DEGs, which was used to construct a miRNA-DEGs network, including 181 interaction pairs and 24 DEGs. As shown in Figure 5 , Asf1b and Anln were regulated by mmu-miR-703, which was significantly upregulated in DKD compared with NC (logFC=0.59, p-value=1.46E-02); Arntl was regulated by mmu-miR-669j, which was a DEG in 
Small-molecule drugs similar to TSF treatment
The DEGs, including 180 upregulated and 193 downregulated DEGs, were analyzed by use of the CMAP tool. As a result, 37 small-molecule chemicals with positive mean and enrichment scores were predicted, including thioguanosine, withaferin-A, DL-thiorphan, and menadione, which indicated their potential similarity to TSF for treatment of DKD, and these may exert a synergistic effect (Table 5) .
Discussion
Compared the study of Zhao et al. [13] , more DEGs were screened between NC vs. DKD (2277 vs. 83) and TSF vs. DKD (2182 vs. 13) using the non-strict threshold in our present study, which led to more overlap among 2 comparisons (373 vs. 3, Pgm5, Zbtb16/PLZF, and Abcb1b). Although Pgm5 (phosphoglucomutase 5), Zbtb16/PLZF, and Abcb1b [ATP-binding cassette, subfamily B (MDR/TAP), member 1B] identified by Zhao et al. [13] were also found in our study, subsequent PPI network and topological property analysis excluded their importance (Pgm5, degree=1; Zbtb16/PLZF, degree=0; Abcb1b, degree=3). On the The genes were enriched into Gene ontology (GO) biological process terms and Kyoto encyclopedia of genes and genomes (KEGG) pathways. The genes were differentially expressed between NC and DKD, and significantly reversed by TSF treatment. NC -normal control; DKD -diabetic kidney disease; TSF -Tangshen formula. contrary, we preliminarily identified that Racgap1 (degree=12), Asf1b (degree=9), Anln (degree=6), and Stat5a (degree=4) were particularly important. Asf1b, Anln, and Racgap1 were significantly upregulated in DKD but were downregulated by TSF treatment, while the opposite result was observed for Stat5a, which was downregulated in DKD but upregulated after TSF treatment. These genes were enriched into cell growth (Asf1b, Anln, Racgap1, and Stat5). Arntl, which had a similar expression pattern to Stat5a, was considered to be pivotal because of its involvement in circadian rhythm, a specific pathway enriched by the genes in PPI. Accordingly, we believe TSF may be effective for treatment of DKD by the above pathways, which appears to be in line with previous studies directly or indirectly as shown by the following evidence.
It is widely accepted that glomerular mesangial expansion is one of the main pathologic characteristics of DKD, which develops due to mesangial cell proliferation and excessive accumulation of extracellular matrix (ECM) proteins [22] [23] [24] . Thus, suppressing cell growth to manage DKD has been extensively investigated in recent years [22] [23] [24] . In the present study we showed that TSF may also be effective for DKD by this mechanism because the related genes have been demonstrated to be associated with cell proliferation. It has been reported that depletion of histone H3-H4 chaperone Asf1b severely compromises proliferation, leading to aberrant nuclear structures and a distinct transcriptional signature, while its overexpression increases cellular proliferation, promoting tumor progression and predicting poor outcomes [25] . This effect of Asf1b was also observed in b cell proliferation [26] . Anln is an actin-binding protein required for cytokinesis. Similarly, several studies have proved Anln plays a critical role in human carcinogenesis and serves as a poor prognostic biomarker [27, 28] . Knockdown of Anln by lentivirus results in G2/M phase arrest, cell growth, and migration inhibition, achieving the treatment goal for cancer [28, 29] . Racgap1 is a component of the central spindle protein complex and is also essential for orchestrating cell division. Thus, its upregulated expression increases the potential of cell excessive proliferation and induces cancer [30] . However, there were no studies focusing on their roles (Cdc25b, Asf1b, Anln, and Racgap1) in DKD and they may be novel targets, which require further experiments to confirm.
Although the study of Hu et al. [15] has demonstrated TSF may be beneficial for DKD treatment via regulating the JAK/STAT/ SOCS signaling pathway, only the expressions of Stat3 (upregulated) and Stat4 (downregulated) were detected. Stat5 was also upregulated after TSF in our study, indicating similar function to Stat3. Furthermore, a recent study indicates Racgap1 appears to be involved cytokinesis by translocation of Stat3. Both Racgap1 inhibitor and siRNA-mediated silencing treatment resulted in increased Stat3 phosphorylation and STAT3-driven transcriptional activity [31] . Thus, we speculated there was also an interaction between Racgap1 and Stat5, which was demonstrated in our PPI network. Also, Racgap1 was observed to interact with Anln and Asf1b. Therefore, Racgap1 may be an especially pivotal target in the treatment of TSF for DKD.
Normal circadian rhythms are crucial for maintaining physiological and functional homeostasis; once disrupted, pathological diseases may be triggered, such as diabetes [32] . Several studies have demonstrated the expression of clock (Per1, Period circadian clock 1; Per2; Arntl; CLOCK, circadian locomotor output cycles kaput; Cry1, cryptochrome 1), as well as clock-controlled genes (Dbp, D site albumin promoter binding protein; E4bp4, also known as NFIL3, nuclear factor, interleukin 3, regulated; RevErba, also known as NR1D1, nuclear receptor subfamily 1, group D, member 1; Rora, RAR-related orphan receptor alpha; Pparg, peroxisome proliferator activated receptor gamma) were significantly changed in diabetes [33] [34] [35] [36] . Although the master circadian system is located in the suprachiasmatic nucleus of the anterior hypothalamus, peripheral organs are also involved, including heart [37] , liver [34] , kidney, lung, and pancreas [35] , indicating that dysfunction of circadian rhythms may be an underlying mechanism for DKD. Studies have investigated the circadian rhythms with DKD, but most of them mainly focused on blood pressure circadian rhythm; blood pressure circadian rhythm of CKD patients frequently shows a non-dipper pattern. The average 24-h, daytime, and Mean -the arithmetic mean of the connectivity scores for corresponding instances; N -the number of instances; Enrichment -A measure of the enrichment of those instances in the order list of all instances; P -an estimate of the likelihood that the enrichment of a set of instances in the list of all instances in a given result would be observed by chance.
nighttime blood pressure in the patients with DKD were all significantly higher than those of patients with non-DKD, and these blood pressure parameters were found to be significantly correlated with albuminuria [38, 39] . No studies explored the circadian rhythm-related genes in renal tissues of DKD. The present study is the first to show that Arntl is significantly downregulated in the renal tissues of diabetic mice. Arntl encodes a basic helix-loop-helix/Per-Arnt-Sim transcription factor that forms a heterodimer with CLOCK and then binds E-box enhancer elements upstream to activate transcription of Period (Per1, Per2, and Per3) and Cryptochrome (Cry1 and Cry2) genes. Downregulation of Arntl leads to lower expressions of Period and Cryptochrome genes, followed by upregulating cellular proliferation and transformation related genes (Cdkn1a, cyclin-dependent kinase inhibitor 1A; Cyclin E1; Claudin 1 and 12; and sFRP1, and secreted frizzled-related protein 1), contributing to the lesion damages in the kidney [40] . Therefore, restoring normal circadian rhythm by altering the expressions of these genes may be a potential approach for treatment of diabetes and its subsequent DKD [41] . As anticipated, Arntl was significantly upregulated in diabetic mice after TSF treatment, suggesting TSF may exert therapeutical effects on DKD by restoring normal circadian rhythm.
In addition to genes, increasing evidence suggests miRNAs may also be important for the development of DKD by either degrading the target mRNAs or inhibiting their translation via binding to the 3'-untranslated regions (UTR miR-21 was demonstrated to promote renal fibrosis in DKD by targeting SMAD7, followed by enhancing TGF-b1-induced epithelial-to-mesenchymal transition [42, 43] ; downregulated miR-451 leads to overexpression of large multifunctional protease 7 (LMP7), which promotes NF-kB-mediated inflammation in mesangial cells and progression of DKD [44] . Thus, inhibition of miRNAs may be an underlying mechanism for treatment of DKD, which has also been reported by several studies [45, 46] . Accordingly, miRNAs that regulated our crucial genes were also predicted and compared with the differentially-expressed miRNAs. The results suggest that only the Arntl-related mmumiR-669j was significantly differentially expressed in the 2 groups and it has not been reported previously in DKD, indicating mmu-miR-669j may be a new target we identified and needs further experiments to confirm.
Moreover, the small-molecule drugs were also investigated to explore a combined strategy or indirectly demonstrate the role of TSF for treatment of DKD. The results showed withaferin A, DL-thiorphan, and menadione may have potential similar to TSF for treatment of DKD. The treatment effects of some smallmolecule drugs on diabetes have also been demonstrated in previous studies. For example, it was reported that withaferin-A treatment marginally reduced the body weight of ob/ob and db/db mice and improved glucose homeostasis, which was also Stat3-mediated [47] .
Conclusions
Our study reveals that TSF may be an effective and safe alternative for treatment of DKD via inhibiting Racgap1-stata5-mediated cell proliferation and restoring miR-669j-Arntl-related circadian rhythm. Further in vitro and in vivo studies are needed to confirm these conclusions, which may be our team's future research focus.
